Issue 6/2020
Content (9 Articles)
Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances
- Infliximab
- Leading Article
Shuai Shao, Gang Wang, Emanual Maverakis, Johann E. Gudjonsson
Advances in Long-Acting Agents for the Treatment of HIV Infection
- Human Immunodeficiency Virus
- Leading Article
Aadia I. Rana, Jose R. Castillo-Mancilla, Karen T. Tashima, Raphael L. Landovitz
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
- Rosacea
- Review Article
Harrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, Christian Paba, Abdullah A. Cheema, Ryan S. Kim, Anat Galor
Potential for Harm Associated with Discharge Opioids After Hospital Stay: A Systematic Review
- Opioids
- Systematic Review
Gerardo A. Arwi, Stephan A. Schug
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
- Open Access
- Dapagliflozin
- Original Research Article
Mala Dharmalingam, S. R. Aravind, Hemant Thacker, S. Paramesh, Brij Mohan, Manoj Chawla, Arthur Asirvatham, Ramesh Goyal, Jayashri Shembalkar, R. Balamurugan, Pradnya Kadam, Hansraj Alva, Rahul Kodgule, Monika Tandon, Sivakumar Vaidyanathan, Amol Pendse, Rajesh Gaikwad, Sagar Katare, Sachin Suryawanshi, Hanmant Barkate
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
- Breast Cancer
- Adis Drug Evaluation
Connie Kang, Yahiya Y. Syed